Vimarsana
Biggest News Aggregation in the World

Page 22 - Ischemic Stroke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ischemic Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ischemic Stroke Today - Breaking & Trending Today

Cleveland-based Enspire DBS Therapy raises $17.6 million - Vimarsana News

Cleveland-based Enspire DBS Therapy raises $17.6 million

The clinical-stage Cleveland company said proceeds from the financing will enable the initiation of the pivotal clinical trial called RESTORE.

Does long-term, daily low-dose aspirin treatment affect the incidence of stroke or intracerebral bleeding? - Vimarsana News

Does long-term, daily low-dose aspirin treatment affect the incidence of stroke or intracerebral bleeding?

Researchers found that older adults who took aspirin had a 38% higher risk of intracranial bleeding.

Study evaluates impact of stent retriever tip design on distal embolization during mechanical thrombectomy - Vimarsana News

Study evaluates impact of stent retriever tip design on distal embolization during mechanical thrombectomy

Research presented today at the Society of NeuroInterventional Surgery's (SNIS) 20th Annual Meeting shows that different types of stent retriever tips may result in improved patient outcomes when performing mechanical thrombectomy to treat stroke.

New criteria could dramatically increase rates of endovascular thrombectomy - Vimarsana News

New criteria could dramatically increase rates of endovascular thrombectomy

A recent study presented today at the Society of NeuroInterventional Surgery's (SNIS) 20th Annual Meeting noted that U.S. rates of endovascular thrombectomy, a lifesaving stroke treatment, are projected to increase dramatically based on new criteria.

Enspire DBS Therapy of Cleveland raises $17.6 million | Crain's Cleveland Business - Vimarsana News

Enspire DBS Therapy of Cleveland raises $17.6 million | Crain's Cleveland Business

The clinical-stage Cleveland company, which is developing an implantable neuromodulation therapy for post-stroke recovery, said proceeds from the financing will enable the initiation of the pivotal clinical trial called RESTORE.